Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-11

Clinical Trial Update: Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigated resveratrol to reduce acute secondary brain injury after sports-related concussions in boxers; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resveratrol (resveratrol)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Sports Concussion | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-11